Alexion Pharmaceuticals Inc (ALXN)

ALXN (NASDAQ:Drugs)
$185.15
neg -2.90
-1.50%
Today's Range: 182.06 - 189.72 | ALXN Avg Daily Volume: 1,115,400
Last Update: 01/30/15 - 12:17 PM EST
Volume: 882,953
YTD Performance: 1.63%
Open: $186.81
Previous Close: $188.05
52 Week Range: $136.37 - $203.30
Oustanding Shares: 198,286,879
Market Cap: 35,251,441,349
6-Month Chart
TheStreet Ratings Grade for ALXN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 12 12 12 11
Moderate Buy 1 1 1 1
Hold 2 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.30 1.30 1.30 1.32
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 74.08
Price Earnings Comparisons:
ALXN Sector Avg. S&P 500
74.08 74.20 25.58
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-1.28% 40.62% 149.40%
GROWTH 12 Mo 3 Yr CAGR
Revenue 36.80 1.87 0.42
Net Income -0.80 1.61 0.37
EPS -1.40 1.35 0.32
Earnings for ALXN:
EBITDA 0.60B
Revenue 1.55B
Average Earnings Estimates
Qtr (03/15) Qtr (06/15) FY (12/15) FY (12/16)
Average Estimate $1.29 $1.33 $5.51 $6.97
Number of Analysts 1 1 4 4
High Estimate $1.29 $1.33 $5.93 $7.91
Low Estimate $1.29 $1.33 $5.05 $5.37
Prior Year $1.41 $0.99 $4.64 $5.51
Growth Rate (Year over Year) -8.51% 34.34% 18.70% 26.51%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Bearish
Jan 30, 2015 | 7:49 AM EST
Shares of ALXN now seen reaching $186, according to Credit Suisse. Estimates also reduced, given the company's currency headwinds. Neut...

Braving Biotech Real Money Pro($)

Do you need to pick one name?
They are prone to being whipsawed by news.
Bearish
Jan 05, 2015 | 6:36 AM EST
ALXN was downgraded from Overweight to Equal-weight, Morgan Stanley said. $202 price target. Valuation call, as the company has limited...
A few stocks that could break higher.
As these examples illustrate, it's just good risk management.
Some growth leaders in the sector are getting technical support.

Off the Charts Real Money Pro($)

Updating our current trade ideas.
The stock seems liable to reenter its uptrend, so here's how to play it.
Cautionary tales that the IPO window might be closing at last.

Columnist Conversations

Market slightly down despite the boost Amazon (AMZN) is giving the NASDAQ. Biotech also continues to be a stro...
There are a number of interesting technical signals on the weekly and daily Berkshire Hathaway (BRK/B) charts....
TheStreet breaks down three things a newly minted publicly traded Shake Shack must do to have success...and ke...
if you got some sell half right now

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.